Letermovir Impurities and its Related Products



Displaying 13 results of Letermovir Impurities

Letermovir impurities are the unintended substances that may be present in commercial or laboratory-grade samples of Letermovir, a potent antiviral drug used to treat cytomegalovirus infections. These impurities can adversely affect the safety, efficacy, and stability of the drug, and therefore, their identification, characterization, and monitoring are critical to ensure the quality and purity of Letermovir formulations. Various analytical techniques, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR), are used to detect and quantify Letermovir impurities and validate the drug's compliance with regulatory standards.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
1-(2-Bromo-6-Fluorophenyl)-3-(2-Methoxy-5-(Trifluoromethyl)P... Impurities CS-O-48633 917389-23-2 In Stock
2-hydroxy Letermovir Impurity Impurities CS-O-54107 Not Available Enquire
3-FluoroLetermovir Impurity Impurities CS-O-46617 Not Available Enquire
3-hydroxyphenyl Letermovir impurity Impurities CS-O-54108 Not Available Enquire
4-FluoroLetermovir Impurity Impurities CS-O-46618 Not Available Enquire
5-FluoroLetermovir Impurity Impurities CS-O-46619 Not Available Enquire
ent-Letermovir Impurities CS-O-54810 917389-37-8 Enquire
Letermovir Ethyl Ester Impurities CS-O-46609 2758792-79-7 Enquire
Letermovir Impurity 11 Impurities CS-EO-04117 2991059-69-7 Enquire
Letermovir Methyl Ester Impurities CS-O-46608 917389-29-8 Enquire
Letermovir, racemic mixture Impurities CS-EK-02074 791116-51-3 Enquire
Letermovir-2,8-bis(4-(3-methoxyphenyl)piperazin impurity Impurities CS-O-54850 Not Available Enquire
N-DesMethylanisole Letermovir rac Impurities CS-O-54106 Not Available Enquire